Elsevier

Hepatology

Volume 22, Issue 3, September 1995, Pages 994-996
Hepatology

Hepatology elsewhere
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation: Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Bacchi CE, Marsh CL, et al. J Pharmacol Exp Ther 1994;271:549–556

https://doi.org/10.1016/0270-9139(95)90325-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (8)

  • PB Watkins

    Drug metabolism by cytochromes P450 in the liver and small bowel

    Gastroenterol Clin North Am

    (1992)
  • L Pichard et al.

    Cyclosporin A drug interactions: screening for inducers and inhibitors of cytochrome P450 (Cyclosporin A Oxidase) in primary cultures of human hepatocytes and in liver microsomes

    Drug Metab Dispos

    (1990)
  • KE Thummel et al.

    Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients

    J Pharmacol Exp Ther

    (1994)
  • DK Turgeon et al.

    Erythromycin breath test predicts oral clearance of cyclosporine A in renal transplant recipients

    Clin Pharmacol Ther

    (1992)
There are more references available in the full text version of this article.

Cited by (0)

View full text